PAVmed's market cap is currently $9.38M. The company's EPS TTM is $-0.74; its P/E ratio is 0.37; PAVmed is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
